AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Viemed Healthcare missed top-line and bottom-line estimates for Q3, with revenue of $71.91M, a 24.0% YoY increase, but $0.09M short of expectations. Adjusted EBITDA for the quarter totaled $16.1 million, a 15.5% increase YoY. The company also narrowed its FY25 revenue outlook, which may impact investor sentiment.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet